Cardiocast

Reducing heart failure readmissions raises mortality

This week from MDedge Cardiology, the Hospital Readmissions Reduction Program may be doing more harm than good, ticagrelor holds no edge over aspirin in CABG patients, weight-loss apps lack evidence, and the Surgeon General sends out an alarm.

Subscribe to Cardiocast wherever you get your podcasts.

Amazon Alexa
Apple Podcasts

Recommended Reading

ADVENT-HF early results: High ASV compliance, no safety concerns
MDedge Internal Medicine
Antimalarial-induced cardiomyopathy in lupus may be underrecognized
MDedge Internal Medicine
Heart cell transplant rejections
MDedge Internal Medicine
Palliative care update highlights role of nonspecialists
MDedge Internal Medicine
Exercise improves outcomes for patients with heart failure and OSA
MDedge Internal Medicine
PIONEER-HF secures place for sacubitril/valsartan in this heart failure doc’s practice
MDedge Internal Medicine
PIONEER-HF called “practice changing” for acute decompensated heart failure
MDedge Internal Medicine
Mylan issues voluntary recall of certain valsartan-containing products
MDedge Internal Medicine
Heart disease remains the leading cause of death in U.S.
MDedge Internal Medicine
TRED-HF: Despite recovery, dilated cardiomyopathy returns after halting HF drugs
MDedge Internal Medicine